Therefore, it is possible that metformin regulates E2F8 through this pathway because metformin has been shown to suppress cAMP/CREB signaling through phosphorylation of CREB binding protein (CBP) in hepatoma cells [33]. The gene discussed is E2F8; the disease is hepatocellular carcinoma.